DermaDetect is an AI driven software company enables the remote diagnosis and treatment of skin disorders for a growing market needs.
Their vision is to provide the remote diagnosis treatment of skin disorders for everyone, anytime anywhere.
The key figures in the company are Ran Ken Tor, CEO, Dr Ouriel Barzilay CTO, and Prof Arie Ingber, founder and Medical adviser, Dermatology.
According to DermaDetect, the biggest problem in the insurance sector is delay in skin disorder diagnosis that results with : late diagnosis resulting in longer treatment process, higher treatment fees, more complications and higher burden to the insurance companies.
How your product can assist in solving the problem?
DermaDetect: Our solution can shorten the delay by providing the first line of skin disorder triage with reference to the possible case and solution – saving time, effort and money to the insurance company.
What is your business model?
DermaDetect: annual licensing fee at a very reasonable costs.
what are the values for insurance companies?
DermaDetect: saves money and time. improve the customer’s services and satisfaction. The insurers should introduce the DermaDetect solution with their insured customers.
Is there any other kinds of customers you are approaching?
DermaDetect: health services, telemedicine services and pharmaceutical companies.
What investments were made in the company so far?
DermaDetect:3M USD of angels and 2.M USD as non-diluted grants from the IIA.
What deals have you signed so far?
DermaDetect: Maccabi HMO, Chanson China – telemedicine solutions, AIMD Canada and trustr USA / Asia.
